Characterization of hepatitis B virus genotypes/subgenotypes in 1301 patients with chronic hepatitis B in North China

Chinese Medical Journal

Volumn 124, Issue 24, 2011, Pages 4178-4183

  Li, Xiao Dong ^a   Wang, Lin ^a   Liu, Yan ^a   Xu, Zhi Hui ^a   Dai, Jiu Zeng ^a   Li, Le ^a   Yao, Zeng Tao ^a   Xin, Shao Jie ^a   Zhao, Jing Ming ^a   Xu, Dong Ping ^a  

^a BEIJING 302 HOSPITAL   (China)

Author keywords

Basal core promoter; Drug resistance; Genotype; Hepatitis b virus; Mutation; Precore

Indexed keywords

ALANINE AMINOTRANSFERASE; HEPATITIS E ANTIGEN; LAMIVUDINE; SERUM ALBUMIN; VIRUS DNA;

ADULT; ANTIVIRAL RESISTANCE; ARTICLE; CHINA; CONTROLLED STUDY; DNA SEQUENCE; FEMALE; GENE MUTATION; GENOTYPE; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PROMOTER REGION; SEROPREVALENCE; VIRUS CHARACTERIZATION; VIRUS CORE; VIRUS DETECTION; VIRUS GENOME; VIRUS INFECTIVITY;

ADULT; ANTIVIRAL AGENTS; CHINA; DNA, VIRAL; DRUG RESISTANCE, VIRAL; FEMALE; GENOTYPE; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HUMANS; MALE; MIDDLE AGED; MUTATION;

EID: 84862926287     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0366-6999.2011.24.011     Document Type: Article

References (28)

1. Lu FM, Zhuang H. Management of hepatitis B in China. Chin Med J 2009; 122: 3-4.
2. Buti M, Rodriguez-Frias F, Jardi R, Esteban R. Hepatitis B virus genome variability and disease progression: the impact of pre-core mutants and HBV genotypes. J Clin Virol 2005; 34: 79-82.
3. Chan HL, Tsang SW, Wong ML, Tse CH, Leung NW, Chan FK, et al. Genotype B hepatitis B virus is associated with severe icteric flare-up of chronic hepatitis B virus infection in Hong Kong. Am J Gastroenterol 2002; 97: 2629-2633.
4. Ren X, Xu Z, Liu Y, Li X, Bai S, Ding N, et al. Hepatitis B virus genotype and basal core promoter/precore mutations are associated with hepatitis B-related acute-on-chronic liver failure without pre-existing liver cirrhosis. J Viral Hepat 2010; 17: 887-895.
5. Chan HL, Wong ML, Hui AY, Hung LC, Chan FK, Sung JJ. Hepatitis B virus genotype C takes a more aggressive disease course than hepatitis B virus genotype B in hepatitis B e antigen-positive patients. J Clin Microbiol 2003; 41: 1277-1279.
6. Kao JH, Chen PJ, Lai MY, Chen DS. Hepatitis B genotypes correlate with clinical outcomes in patients with chronic hepatitis B. Gastroenterol 2000; 118: 554-559.
7. Yin J, Zhang H, Li C, Gao C, He Y, Zhai Y, et al. Role of hepatitis B virus genotype mixture, subgenotypes C2 and B2 on hepatocellular carcinoma: compared with chronic hepatitis B and asymptomatic carrier state in the same area. Carcinogenesis 2008; 29: 1685-1691.
8. Zhu L, Tse CH, Wong VW, Chim AM, Leung KS, Chan HL. A complete genomic analysis of hepatitis B virus genotypes and mutations in HBeAg-negative chronic hepatitis B in China. J Viral Hepat 2008; 15: 449-458.
9. Zhang HW, Yin JH, Li YT, Li CZ, Ren H, Gu CY, et al. Risk factors for acute hepatitis B and its progression to chronic hepatitis in Shanghai, China. Gut 2008; 57: 1713-1720.
10. Tseng TC, Liu CJ, Chen PJ, Lai MY, Lin CL, Kao JH, et al. Subgenotypes of hepatitis B virus genotype C do not correlate with disease progression of chronic hepatitis B in Taiwan. Liver Int 2007; 27: 983-988.
11. Tong S, Kim KH, Chante C, Wands J, Li J. Hepatitis B Virus e Antigen Variants. Int J Med Sci 2005; 2: 2-7.
12. Orito E, Mizokami M, Sakugawa H, Michitaka K, Ishikawa K, Ichida T, et al. A case-control study for clinical and molecular biological differences between hepatitis B viruses of genotypes B and C. Japan HBV Genotype Research Group. Hepatology 2001; 33: 218-223.
13. Rodriguez-Frias F, Jardi R, Buti M, Schaper M, Hermosilla E, Valdes A, et al. Hepatitis B virus genotypes and G1896A precore mutation in 486 Spanish patients with acute and chronic HBV infection J Viral Hepat 2006; 13: 343-350.
14. Yuan J, Zhou B, Tanaka Y, Kurbanov F, Orito E, Gong Z, et al. Hepatitis B virus (HBV) genotypes/subgenotypes in China: mutations in core promoter and precore/core and their clinical implications. J Clin Virol 2007; 39: 87-93.
15. Choi JW, Ahn SH, Park JY, Chang HY, Kim JK, Baatarkhuu O, et al. Hepatitis B e antigen-negative mutations in the precore and core promoter regions in Korean patients. J Med Virol 2009; 81: 594-601.
16. Inoue J, Ueno Y, Wakui Y, Niitsuma H, Fukushima K, Yamagiwa Y, et al. Four-year study of lamivudine and adefovir combination therapy in lamivudine-resistant hepatitis B patients: influence of hepatitis B virus genotype and resistance mutation pattern. J Viral Hepat 2010; 18: 206-215.
17. Chien RN, Yeh CT, Tsai SL, Chu CM, Liaw YF. Determinants for sustained HBeAg response to lamivudine therapy. Hepatology 2003; 38: 1267-1273.
18. Hsieh TH, Tseng TC, Liu CJ, Lai MY, Chen PJ, Hsieh HL, et al. Hepatitis B virus genotype B has an earlier emergence of lamivudine resistance than genotype C. Antivir Ther 2009; 14: 1157-1163.
19. Buti M, Cotrina M, Valdes A, Jardi R, Rodriguez-Frias F, Esteban R. Is hepatitis B virus subtype testing useful in predicting virological response and resistance to lamivudine? J Hepatol 2002; 36: 445-446.
20. Chinese Society of Hepatology and Chinese Society of Infectious Diseases, Chinese Medical Association. The guideline of prevention and treatment for chronic hepatitis B (2010 version). Chin J Epidemiol (Chin) 2011; 32: 405-415.
21. + regulatory T cells actively influence the antiviral immune response and disease progression in patients with hepatitis B. J Immunol 2006; 177: 739-747.
22. Liu Y, Wang CM, Cheng J, Liang ZL, Zhong YW, Ren XQ, et al. Hepatitis B virus in tenofovir-naive Chinese patients with chronic hepatitis B contains no mutation of rtA194T conferring a reduced tenofovir susceptibility. Chin Med J 2009; 122: 1585-1586.
23. Liu Y, Zhong Y, Zou Z, Li B, Ren X, Bai S, et al. Features and clinical implications of hepatitis B virus genotypes and mutations in basal core promoter/precore region in 507 Chinese patients with acute and chronic hepatitis B. J Clin Virol 2010; 47: 243-247.
24. Xu Z, Liu Y, Xu T, Chen L, Si L, Wang Y, et al. Acute hepatitis B infection associated with drug-resistant hepatitis B virus. J Clin Virol 2010; 48: 270-274.
25. Lok AS, Zoulim F, Locarnini S, Bartholomeusz A, Ghany MG, Pawlotsky JM, et al. Antiviral drug-resistant HBV: standardization of nomenclature and assays and recommendations for management. Hepatology 2007; 46: 254-265.
26. Baldick CJ, Tenney DJ, Mazzucco CE, Eggers BJ, Rose RE, Pokornowski KA, et al. Comprehensive evaluation of hepatitis B virus reverse transcriptase substitutions associated with entecavir resistance. Hepatology 2008; 47: 1473-1482.
27. Wang HY, Li D, Liu W, Jin X, Du B, Li YP, et al. Hepatitis B virus subgenotype C2 is the most prevalent subgenotype in northeast China. Clin Microbiol Infect 2010; 16: 477-481.
28. Yang R, Xu C, Xu Z, Xu D, Huang W, Maertens R, et al. INNO-LiPA HBV genotyping is highly consistent with direct sequencing and sensitive in detecting B/C mixed genotype infection in Chinese chronic hepatitis B patients and asymptomatic HBV carriers. Clin Chim Acta 2010; 411: 1951-1956.